Research Techniques Made Simple: Pragmatic or Explanatory Trial? The BLISTER Study The Bullous Pemphigoid Steroids and Tetracyclines Study Hywel Williams.

Slides:



Advertisements
Similar presentations
Different types of trial design
Advertisements

PrECIs (Pragmatic-Explanatory Continuum Indicators) “Spokes” Dave Sackett, on behalf of at least 23 collaborators.
Copyright H Photography 2006 iStockphoto.com Pragmatic cohort studies and comparative effectiveness Eric S Johnson, PhD Kaiser Permanente’s Center for.
Treatment Switching in the VenUS IV trial Methods to manage treatment non-compliance in RCTs with time-to-event outcomes Caroline Fairhurst York Trials.
1 Health and Disease in Populations 2002 Week 9 – 2/5/02 Randomised controlled trials 2 Dr Jenny Kurinczuk.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Clinical Trials Importance in future therapies. What are the Requirements to Produce New Drugs? Drug must work significantly better than a control treatment.
Design and Analysis of Clinical Study 12. Randomized Clinical Trials Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2013.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2009.
Pragmatic or explanatory trial? Hywel Williams University of Nottingham with help from Daniel Bratton and Andrew Nunn MRC Clinical Trials Unit HTA reference.
Journal Club Alcohol and Health: Current Evidence May–June 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2011.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2009.
Evidence-based Medicine Journal Club Khalid Bin Abdulrahman Director of Medical Education Center King Saud University.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Journal Club Alcohol and Health: Current Evidence September–October 2004.
Clinical Trials Hanyan Yang
Pragmatic Randomised Trials. Background Many clinical trials take place in artificial conditions that do not represent NORMAL clinical practice. Often.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
Journal Club Alcohol and Health: Current Evidence January–February 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2009.
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U. Evidence-based medicine.
POST- RANDOMIZATION DATA ANALYSIS OGNEN JAKASANOVSKI
Critical Appraisal of an Article on Therapy (2). Formulate Clinical Question Patient/ population Intervention Comparison Outcome (s) Women with IBS Alosetron.
Mother and Child Health: Research Methods G.J.Ebrahim Editor Journal of Tropical Pediatrics, Oxford University Press.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 18 Mixed Methods and Other Special Types of Research.
Lecture 16 (Oct 28, 2004)1 Lecture 16: Introduction to the randomized trial Introduction to intervention studies The research question: Efficacy vs effectiveness.
What is a Clinical Trial (alpha version) John M. Harris Jr., MD President Medical Directions, Inc.
My Own Health Report: Case Study for Pragmatic Research Marcia Ory Texas A&M Health Science Center Presentation at: CPRRN Annual Grantee Meeting October.
Study design P.Olliaro Nov04. Study designs: observational vs. experimental studies What happened?  Case-control study What’s happening?  Cross-sectional.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2012.
Systematic Review Module 7: Rating the Quality of Individual Studies Meera Viswanathan, PhD RTI-UNC EPC.
Evidence-Based Journal Article Presentation [Insert your name here] [Insert your designation here] [Insert your institutional affiliation here] Department.
The Intervention Program THE MISSING LINK IN BIOPHARMACEUTICAL SCIENCES TM.
EBM --- Journal Reading Presenter :顏志維 Date : 2005/10/17.
Copyright © 2013, 2009, and 2007, Pearson Education, Inc. Chapter 4 Gathering Data Section 4.3 Good and Poor Ways to Experiment.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Introduction Clinical trials Why clinical trials? Process of a clinical trial Informed consent Patients‘ interests Rights and protection Study Registers.
How to Analyze Therapy in the Medical Literature (part 1) Akbar Soltani. MD.MSc Tehran University of Medical Sciences (TUMS) Shariati Hospital
Making epidemiological evidence more accessible using pictures Rod Jackson Updated November 09.
Study designs. Kate O’Donnell General Practice & Primary Care.
Critical Appraisal (CA) I Prepared by Dr. Hoda Abd El Azim.
PTP 661 EVIDENCE ABOUT INTERVENTIONS CRITICALLY APPRAISE THE QUALITY AND APPLICABILITY OF AN INTERVENTION RESEARCH STUDY Min Huang, PT, PhD, NCS.
EBM --- Journal Reading Presenter :呂宥達 Date : 2005/10/27.
Is the conscientious explicit and judicious use of current best evidence in making decision about the care of the individual patient (Dr. David Sackett)
HTA Efficient Study Designs Peter Davidson Head of HTA at NETSCC.
بسم الله الرحمن الرحیم.
Why are we Here? Russell E. Glasgow, Ph.D. University of Colorado School of Medicine With thanks to the NIH Health Care Systems Research Collaboratory.
WELCOME! Pragmatic Trials Training Workshop 2014.
Critical Appraisal Course for Emergency Medicine Trainees Module 3 Evaluation of a therapy.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2013.
PRAGMATIC Study Designs: Elderly Cancer Trials
The PRECIS-2 tool: Matching Intent with Methods David Hahn, MD, MS, WREN Director Department of Family Medicine & Community Health University.
Translating Research Into Practice: Pragmatic Research Approaches
Sample Journal Club Your Name Here.
Chrissie Fletcher, Amgen Ltd on behalf of IMI GetReal
Alcohol, Other Drugs, and Health: Current Evidence
Study Population and Setting
Interventional trials
Randomized Trials: A Brief Overview
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
PRECISely how can PRECIS-2 help design trials to achieve practical answers to “real world” questions? Kirsty Loudon Impact Fellow NMAHP Research Unit  
Regulatory Perspective of the Use of EHRs in RCTs
Presentation transcript:

Research Techniques Made Simple: Pragmatic or Explanatory Trial? The BLISTER Study The Bullous Pemphigoid Steroids and Tetracyclines Study Hywel Williams University of Nottingham with help from Daniel Bratton and Andrew Nunn MRC Clinical Trials Unit HTA reference 06/403/51 ISRCTN

Pragmatic study – does it work in my clinic? Treatment already known to work, but can it work in real-world clinical practice? - effectiveness Wider group of participants – more comorbidities, less compliant Maybe in a primary care setting Flexible dosing, switching, and rescue therapy compatible with daily practice – “policy” of a treatment pathway rather than one drug Cost-effectiveness is key

Explanatory trials - can it work? Conducted under “ideal” conditions Highly selected and homogeneous participants Usually tertiary care Good compliance Likely to remain in study Only one medical condition Strict dosing schedules Monitored closely To “explain” if a treatment works - efficacy

PICOT comparison Pragmatic Homogenous patients Tightly defined intervention Clearly defined control group – often placebo Objective/surrogate outcomes Short-term follow-up time, e.g., 6 weeks Real-life patients Flexible intervention with changes Active comparator Clinically important outcomes Longer-term follow-up times, e.g., 6 months

Pragmatic does not mean “anything goes” Still have to fiercely minimize bias 1.Selection - Randomization and allocation concealment 2.Performance – similar conditions for both groups 3.Detection bias – blinded outcome 4.Attrition bias – collecting data on dropout and intention-to-treat analysis

Back to BLISTER..... Is it explanatory or pragmatic? X wrong question To what extent is it explanatory or pragmatic? √ right question Thorpe KE et al: A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers. Journal of Clinical Epidemiology 2009, 62:

More about PRECIS The Pragmatic-Explanatory Continuum Indicator Summary Typically used as a tool when designing study Requires a judgment on key aspects of trial design Illustrated by a PRECIS wheel

A blank pragmatic - explanatory continuum indicator summary (PRECIS) ‘‘wheel.’’

Applied PRECIS to BLISTER Sent to six TMG members Two pemphigoid experts One clinician interested in clinical trials Two trial statisticians

Summary points Described explanatory and pragmatic trials A continuum, not a dichotomy Applied PRECIS wheel to BLISTER Pragmatic studies are not an excuse for bias Most clinical trials that change clinical practice need to be pragmatic